Andrew Bowskill
@drewabow.bsky.social
Co-chair, the Australian Antimicrobial Resistance Network (AAMRNet)
‘Pharma companies make money on a new drug by selling a lot or charging a lot - but with antimicrobials neither is possible.’ - Andrew Bowskill #AAMRNet. Delinking funding from use is the only way to stimulate investment in new antimicrobials #MTPConnect #AMR #antimicrobials @drewabow.bsky.social
Australian universities urge Albanese to join New Zealand in $170bn Europe fund amid Trump attacks on education
Australian universities urge Albanese to join New Zealand in $170bn Europe fund amid Trump attacks on education
Horizon Europe counts the UK and Canada among it’s partners, but industry insiders say Australia is concerned about the cost * Get our breaking news email, free app or daily news podcast Australian universities are urging the Albanese government to join New Zealand in a $170bn Europe research fund amid US president Donald Trump’s sweeping crackdown on higher education and international students. Universities Australia’s executive officer, Luke Sheehy, travelled to Brussels this week to meet representatives from the European Commission and the Australian ambassador, Angus Campbell, to discuss the possibility of joining Horizon Europe. Sign up for Guardian Australia’s breaking news email Continue reading...
theguardian.com
Timely access to appropriate antimicrobials is essential for patient care, antimicrobial stewardship & minimising the risk of resistance - excellent summary of the issues here: amr.solutions/2025/04/07/y... Thanks to @johnhrexmd.bsky.social for highlighting our paper #AMR #AntibioticAccess #AMS 💊
You reach for the antibiotic ... and it's not there!
Dear All (with thanks to Louise for co-authoring and with a wonkish alert … settle in for the ride!), Today’s newsletter discusses the intersection of three themes around antibiotic access. Recall fir...
amr.solutions
The access pathway for unregistered medicines in Australia is used extensively to access antimicrobials, including for life-threatening infections Difficulty accessing appropriate antimicrobials is not only a problem affecting LMICs doi.org/10.1093/jaca... @nadinehillock.bsky.social
doi.org
On average, 15–16 patients/day require an antibacterial not registered for use in Australia Highlights that new pathways are needed to register antibacterials for otherwise untreatable infections doi.org/10.1093/jaca... @jac-amr.bsky.social @drewabow.bsky.social @peripatetical.bsky.social #AMR
Do policies that allow access to unregistered antimicrobials address the unmet need? Australia as a case study of a high-income country with universal healthcare
AbstractBackground. Ensuring timely and equitable access to effective and optimal antimicrobials is crucial for optimal patient care, to minimize the use o
doi.org
The survey closes Feb 28 2025 It is important many Australian researchers complete this survey to present as strong a voice as possible for #AMR to be central to the Strategy Thanks to @drewabow.bsky.social and AAMRNet for bringing this to our attention. Sign up to receive the AAMRNet newsletter
Australian Antimicrobial Resistance Network (AAMRNet) : MTPConnect
mtpconnect.org.au
